Skip to main content
Article thumbnail
Location of Repository

The Oxidation of L-Tryptophan in Biology by Human Heme Dioxygenases

By Bibi Sara Ameena Rafice


The full articles from Apendix: Publications have been removed due to copyright restrictions. The definitive version of the thesis can be consulted at the David Wilson Library, University of Leicester.Tryptophan is an essential amino acid, which is catabolised via the kynurenine pathway leading to the formation of NAD. The initial and rate-limiting step of the kynurenine pathway is controlled by two hemoproteins called tryptophan 2,3-dioxygenase (TDO) and indoleamine 2,3-dioxygenase (IDO), which oxidise tryptophan to form N-formyl-kynurenine.\ud A bacterial expression system for hTDO was characterised in Chapter 2. Kinetic, spectroscopic and redox analyses determined that significant differences exist. It was found that hTDO does not form a stable ferrous-oxy complex and that the ferric form of the enzyme was catalytically active. In addition hTDO does not discriminate against substrate binding to the ferric derivative.\ud Site-directed mutagenesis of several active site residues and the role of each residue on substrate binding and in catalysis was examined in Chapter 3. The H76 residue was found to be involved in substrate binding. The phenylalanine variants of TDO showed that the hydrophobicity in the active site was essential for catalytic activity. Furthermore, the data showed that F72 is an important substrate binding residue. The highly conserved arginine residue was deemed to be an essential catalytic residue involved in substrate binding. The implications of these findings are discussed in terms of the current understanding of dioxygenase catalysis.\ud In Chapter 4, it was shown that 1-methyl-tryptophan was a substrate for wild type IDO and variants of TDO and IDO, which is contrary to previous findings in dioxygenase literature. No activity was observed for wild type hTDO. Previous crystallographic studies and modelling in combination with kinetic, spectroscopic and redox analyses indicated that the distal histidine in the TDO active site causes steric clashes with 1-methyl-L-tryptophan. This information indicated exclusion of the deprotonation of the indole N1 mechanism, and an alternative reaction mechanism was presented.\ud A new expression system for IDO with a cleavable hexahistidyl tag was constructed in Chapter 5. The analyses indicated that the recombinant protein had the same characteristics as all other mammalian IDOs and that diffraction quality crystals can be grown from the system. Crystal structures of IDO are required to further the understanding of substrate binding and the catalytic mechanism

Publisher: University of Leicester
Year: 2010
OAI identifier:

Suggested articles


  1. (1998). A myoglobin evolved from indoleamine 2,3-dioxygenase, a tryptophan-degrading enzyme, doi
  2. (2000). A neurological perspective of violent behavior., Civic Research Institute,
  3. (1974). A simple graphical method for determining the inhibition constants of mixed, uncompetitive and non-competitive inhibitors, doi
  4. (1948). A spectroscopic method for simultaneous determination o myglobin and hemoglobin in extracts of human muscle, doi
  5. (2004). Association of tryptophan 2,3 dioxygenase gene polymorphism with autism, doi
  6. (2005). Biochemical and medical aspects of the indoleamine 2,3-dioxygenase-initiated L-tryptophan metabolism, doi
  7. (2001). Chemical reactivity of the active site of myoglobin, doi
  8. (2006). Crystal structure of human indoleamine 2,3-dioxygenase: catalytic mechanism of O2 incorporation by a heme-containing dioxygenase, PNAS 103, 2611-2616. variants of TDO in the absence of substrate ( ), doi
  9. (2007). Crystallographic and spectroscopic studies of peroxide-derived myoglobin compound II and occurrence of protonated FeIV doi
  10. (2004). Defining substrate specificity and catalytic mechanism in ascorbate peroxidase, Biochem Soc Symp, doi
  11. (2000). Dual nature of the distal histidine residue in the autoxidation reaction of myoglobin and hemoglobin comparison of the H64 mutants, doi
  12. (1975). EPR Signal Intensity and Powder Shapes: A Reexamination, doi
  13. (2004). Expression of the kynurenine pathway enzyme tryptophan 2,3-dioxygenase is increased in the frontal cortex of individuals with schizophrenia, doi
  14. (1991). Flavins and Flavoproteins doi
  15. (1971). Haemoglobin and Myoglobin and their reactions with ligands, North Holland Publishers, doi
  16. (1978). Indoleamine 2,3-dioxygenase. Purification and some properties,
  17. (2003). Is there a genetic susceptibility to engage in criminal acts?,
  18. (1993). Isotope effects and alternative substrate reactivities for tryptophan 2,3-dioxygenase,
  19. (1969). Mechanisms of two- and four-electron oxidations catalyzed by some metalloenzymes, doi
  20. (2003). Melatonin in plants, doi
  21. (1980). Ommochromes and pteridines,
  22. (1972). Oxidation-Reduction Potentials of Organic Systems, Robert E. doi
  23. (2002). Personality psychology : domains of knowledge about human nature,
  24. (1999). Probability-based protein identification by searching sequence databases using mass spectrometry data, doi
  25. (2001). Relationships between inhibition constants, inhibitor concentrations for 50% inhibition and types of inhibition: new ways of analysing data, doi
  26. (1993). Skin L-tryptophan2,3-dioxygenase and rat hair growth, doi
  27. (1994). SPECFIT, Spectrum Software Associates,
  28. (2005). Structural biology of heme monooxygenases, doi
  29. (2005). Structure and chemistry of cytochrome P450, doi
  30. (2009). Substrate-Protein Interaction in Human Tryptophan Dioxygenase: The Critical Role of H76, doi
  31. (2000). Systematic Analysis of Peptide Recoveries from In-Gel Digestions for Protein Identifications in Proteome Studies,
  32. (1953). The determination of enzyme inhibitor constants, doi
  33. (2009). The expanded biology of serotonin, doi
  34. (2003). The genetic aspects of criminality., doi
  35. (2006). Tryptophan metabolism in the central nervous system: medical implications, doi

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.